Citigroup’s Apollo Endosurgery, Inc. APEN Stock Holding History

Citigroup’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-98,900	Closed	-$986K	–	6012
2022 Q4	$986K	Buy	+98,900	New	+$737K	﹤0.01%	2614

Citigroup's APEN Position: Q2 2023 in Review

Citigroup sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 2,000,000 shares — an estimated $19.8M sold.

Citigroup first reported a position in APEN in Q4 2021 and held it in 6 quarters. The position peaked at $23.8M in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Citigroup reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Citigroup sold 2,000,000 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $19.8M.
Citigroup first reported a position in Apollo Endosurgery, Inc. in Q4 2021 and held it in 6 quarters.
Citigroup's Apollo Endosurgery, Inc. position peaked at $23.8M in Q4 2022.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Citigroup's 13F filing for Q2 2023, filed 10 Aug 2023.